Bringing the fundamentals into focus…
Back to Keros Therapeutics, Inc.
How Keros Therapeutics, Inc. stacks up
KROS · against 218 other Healthcare companies of similar size
Growth
3/ 100
Near the bottom of its peers.
Ranked #209 of 219 · scores higher than 3% of peers
Bars: peers in each 10-point band of the growth score32 peers with a growth score of 0–9, including KROS · Click a bar to see the companies
Why growth scores 3?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 99% of peers. Revenue growth: -93.6% vs peer median 6.1%
- Earnings per share turned from a profit to a loss. Earnings per share growth: — vs peer median 9.8%
- 3-year revenue growth is not reported, so it is left out of the score.
Metric by metric
Position: dot = KROS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KROS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 231 reported | -93.6% | 3.4% | 2% | 33% | |
| Earnings per share growthHigher is better · 89 reported | Not reported | 5.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 212 reported | Not reported | 3.9% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around KROS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 1 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 4 | 5.7B TWD (≈$177M) | 98 | 65 | |
| 4 | 217M AUD (≈$143M) | 98 | 43 | |
| 209 | 2.2B CNY (≈$308M) | 3 | 18 | |
| 209 | 2.3B CNY (≈$322M) | 3 | 10 | |
| 209 | 2.1B CNY (≈$291M) | 3 | 9 | |
| 209 | 271M USD | 3 | 14 | |
| 209 | 215M USD | 3 | 34 | |
| 214 | 366M CHF (≈$421M) | 2 | 23 | |
| 215 | 327M USD | 1 | 11 | |
| 216 | 389M USD | 0 | 33 | |
| 216 | 454M AUD (≈$299M) | 0 | 7 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score